Abstract:Objective: To summarize the clinical and genetic characteristics of mental retardation disorder (MRD) with TRIO gene variant in children. Methods: Case series study. The data of 9 children with TRIO gene variants were collected retrospectively from August 2019 to March 2024 in Department of Neurology, Beijing Children's Hospital, Capital Medical University and Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University. The data included gender, age, intellectual and motor development, appearance, seizures, neuroimaging and genetic results. The clinical features and genotype-phenotype correlations were summarized. Results: Of the 9 children, 6 boys and 3 girls, 4 MRD63 children presented with moderate to severe developmental delays accompanied by macrocephaly; 5 MRD44 children had mild to moderate developmental delays with microcephaly. A total of 5 children had dysmorphic facial features (flat occiput, thick eyebrows, unibrow, large ears, short fingers, pale skin, yellow hair, and strabismus), 2 children experienced seizures (1 child with myoclonic seizure and 1 with absence seizure), 4 children had feeding difficulties, 1 child had congenital cataracts, 1 child had congenital heart disease, 1 child had recurrent infections, and 1 child had tiger-striped changes in the fundus examination. TRIO gene variants carried by the 9 children were all de novo, involving 8 variant sites, including 7 missense variants and 1 frameshift variant, c.3232C>T/p.R1078W (2 cases), c.3920A>G/p.Y1307C, c.4112A>T/p.H1371L, c.4283G>T/p.R1428L, c.4394A>G/p.N1465S, c.6041T>C/p.I2014T, c.6821G>A/p.R2274H, c.7027delC/p.Q2343Sfs*70. Among them, 2 sites are located in the Spectrin domain, 4 sites are in the GEFD1 domain, 2 sites are in the GEFD2 domain, and 1 site (frameshift variant) is in the PH2-SH3 domain. The individual with frameshift variant exhibit absence seizures, mild developmental delay, and the mildest phenotype. The child with myoclonic seizures was treated with valproic acid and levetiracetam for seizure control, while the child with absence epilepsy was treated with valproic acid and lamotrigine for seizure control. All 9 children underwent regular rehabilitation exercises, making slow progress. Conclusions: TRIO gene related MRD is characterized by varying degrees of developmental delay, and often accompanied by macrocephaly or microcephaly, dysmorphic facial features, and with or without seizures. The main variant types are missense variants, which are mostly concentrated in the Spectran domain and GEFD domain. p. R1078W may be a relative hotspot variant. The phenotype caused by the frameshift variant is relatively milder.

RNA analysis and computer‐aided facial phenotyping help to classify a novel TRIO splice site variant

Extending the phenotypes associated with TRIO gene variants in a cohort of 25 patients and review of the literature

Case report: Phenotype expansion and analysis of TRIO and CNKSR2 variations

Neurodevelopmental Disease-Associated De Novo Mutations and Rare Sequence Variants Affect TRIO GDP/GTP Exchange Factor Activity.

[Clinical characteristics and genetic analysis of mental retardation disorder with TRIO gene variant]

Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice

Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach

Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review.

A sensorineural hearing loss harboring novel compound heterozygous variant in the TRIOBP gene: A case report

Identification and Expression Analysis of a Novel Splice Variant of Human Tumor Necrosis Factor Receptor Associated Factor 2

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Novel deep intronic and frameshift mutations causing a <i>TRIP11</i>-related disorder

A deep intronic TCTN2 variant activating a cryptic exon predicted by SpliceRover in a patient with Joubert syndrome

Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits.

The RNA binding protein Nab2 regulates splicing of the RhoGEF transcript to govern axon and dendrite morphology

Identification and characterization of a novel intronic splicing mutation in CSF1R‐related leukoencephalopathy

RNA variant assessment using transactivation and transdifferentiation

Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development

TRPS1 mutation detection in Chinese patients with Tricho-rhino-phalangeal syndrome and identification of four novel mutations

DYNC2H1 splicing variants causing severe prenatal short‐rib polydactyly syndrome and postnatal orofaciodigital syndrome

Psychomotor development and attention problems caused by a splicing variant of CNKSR2